Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
6.48
+0.46 (7.64%)
At close: Jun 26, 2026, 4:00 PM EDT
6.49
+0.01 (0.15%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,464,346
Market Cap
401.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Abeona Therapeutics | 226 |
| Lyell Immunopharma | 161 |
| Nautilus Biotechnology | 127 |
| Verastem | 102 |
| SAB Biotherapeutics | 86 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 55 |
HELP News
- 2 days ago - Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering - GlobeNewsWire
- 3 days ago - Helus Pharma prices 10.31M common shares at $4.85 in public offering - TheFly
- 3 days ago - Helus Pharma says enrollment in APPROACH Phase 3 trial ‘progressing as planned’ - TheFly
- 3 days ago - Helus Pharma™ Announces US$50 Million Underwritten Offering - GlobeNewsWire
- 3 days ago - Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress - GlobeNewsWire
- 12 days ago - Cybin Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference - Transcripts
- 16 days ago - Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference - GlobeNewsWire
- 22 days ago - Cybin Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts